NYSE:PRGO

Perrigo - PRGO Stock Forecast, Price & News

$31.94

-0.20 (-0.62%)

(As of 12/2/2022 09:00 PM ET)

Add

Compare

Today's Range: $31.78
▼
$32.13
50-Day Range: $31.86
▼
$41.31
52-Week Range: $31.30
▼
$43.90

Volume: 942,100 shs
Average Volume: 1.42 million shs
Market Capitalization: $4.30 billion

P/E Ratio: N/A
Dividend Yield: 3.26%
Price Target: $47.33

Perrigo MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 48.2% Upside
$47.33 Price Target
Short Interest: Healthy
3.42% of Shares Sold Short
Dividend Strength: Strong
Based on Four Factors
Sustainability: -1.93
Upright™ Environmental Score
News Sentiment: 0.36
Based on 7 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 38.61%
From $2.02 to $2.80 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.94 out of 5 stars

Medical Sector

24th out of 1,033 stocks

Pharmaceutical Preparations Industry

9th out of 502 stocks

3.5

Analyst's Opinion

Consensus Rating
Perrigo has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $47.33, Perrigo has a forecasted upside of 48.2% from its current price of $31.94.
Amount of Analyst Coverage
Perrigo has only been the subject of 3 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
3.42% of the outstanding shares of Perrigo have been sold short.
Short Interest Ratio / Days to Cover
Perrigo has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Perrigo has recently increased by 17.30%, indicating that investor sentiment is decreasing significantly.

3.3

Dividend Strength

Dividend Yield
Perrigo pays a meaningful dividend of 3.26%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Perrigo has been increasing its dividend for 19 years.
Dividend Sustainability
Based on earnings estimates, Perrigo will have a dividend payout ratio of 37.14% next year. This indicates that Perrigo will be able to sustain or increase its dividend.

3.5

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Perrigo has received a 41.09% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Anti-diarrheal and intestinal anti-inflammatory medication (A07)", "Dental floss", "Antifungal medication (D01) ", "Cough and cold medication (R05)", and "Toothbrushes" products. See details.
Environmental Sustainability
The Environmental Impact score for Perrigo is -1.93.

2.4

News and Social Media Coverage

News Sentiment
Perrigo has a news sentiment score of 0.36. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 7 news articles for Perrigo this week, compared to 5 articles on an average week.
Search Interest
5 people have searched for PRGO on MarketBeat in the last 30 days. This is an increase of 150% compared to the previous 30 days.
MarketBeat Follows
Only 1 people have added Perrigo to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Perrigo insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 0.80% of the stock of Perrigo is held by insiders.
Percentage Held by Institutions
96.41% of the stock of Perrigo is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Perrigo are expected to grow by 38.61% in the coming year, from $2.02 to $2.80 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Perrigo is -50.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Perrigo is -50.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Perrigo has a P/B Ratio of 0.93. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Perrigo (NYSE:PRGO) Stock

Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Receive PRGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Perrigo and its competitors with MarketBeat's FREE daily newsletter.

PRGO Stock News Headlines

December 2, 2022 | americanbankingnews.com

Perrigo (NYSE:PRGO) Sets New 52-Week Low at $31.31

December 1, 2022 | finance.yahoo.com

Reckitt Benckiser expects baby formula shortage to continue into spring 2023

November 30, 2022 | americanbankingnews.com

Perrigo Company plc (NYSE:PRGO) Declares $0.26 Quarterly Dividend

November 10, 2022 | finance.yahoo.com

‘Long-term investors should turn back toward stocks’: J.P. Morgan says inflation has peaked and suggests 2 stocks to buy